Literature DB >> 11432139

Primary total hip replacement: variations in patient management in Oxford & Anglia, Trent, Yorkshire & Northern 'regions'.

R W Morris1, R Fitzpatrick, S Hajat, B C Reeves, D W Murray, D Hannen, M Rigge, O Williams, P J Gregg.   

Abstract

OBJECTIVES: To examine national practice, and variations in practice, concerning total hip replacement; in particular the choice of prosthesis and the involvement of consultants in NHS operations.
DESIGN: Pre-operative survey of patients undergoing total hip replacement.
SETTING: Five English regions serving combined population of 16.8 million people.
SUBJECTS: 13,343 total hip replacement operations in one year commencing September 1996, either in NHS or private sector. MAIN OUTCOME MEASURES: Prosthesis used for surgery, status of surgeons involved in operation, use of laminar flow operating theatre.
RESULTS: Prostheses without well documented 5-year survival were used in 5504 (58%) of 9417 operations for which information was available. The consultant was the operator in 4810 (64%) of 7499 NHS operations. In 1352 trainee-led operations, the consultant was present for only 637 (47%); this figure was 54% for trainees in years 1-4 of their training. Substantial variation between NHS consultant firms occurred both for use of prostheses with well documented survival data, and supervision of trainees by the consultant.
CONCLUSIONS: This large study is the first attempt to describe national practice for primary total hip replacement. Substantial variation among consultant firms was observed for all indices of practice reported.

Entities:  

Mesh:

Year:  2001        PMID: 11432139      PMCID: PMC2503572     

Source DB:  PubMed          Journal:  Ann R Coll Surg Engl        ISSN: 0035-8843            Impact factor:   1.891


  12 in total

1.  Consultant supervision of surgical trainees: an objective assessment of how much actually occurs.

Authors:  P E Dikki; T J Crofts; S J Nixon; R J Aitken
Journal:  Ann R Coll Surg Engl       Date:  1999-03       Impact factor: 1.891

2.  Joint responsibility: the need for a national arthroplasty register.

Authors:  D H Sochart; A J Long; M L Porter
Journal:  BMJ       Date:  1996-07-13

3.  Stanmore compared with Charnley total hip replacement. A prospective study of 413 arthroplasties.

Authors:  R A Marston; A G Cobb; G Bentley
Journal:  J Bone Joint Surg Br       Date:  1996-03

Review 4.  Reduction in fatal pulmonary embolism and venous thrombosis by perioperative administration of subcutaneous heparin. Overview of results of randomized trials in general, orthopedic, and urologic surgery.

Authors:  R Collins; A Scrimgeour; S Yusuf; R Peto
Journal:  N Engl J Med       Date:  1988-05-05       Impact factor: 91.245

Review 5.  Which primary total hip replacement?

Authors:  D W Murray; A J Carr; C J Bulstrode
Journal:  J Bone Joint Surg Br       Date:  1995-07

6.  Prognosis of total hip replacement in Sweden. Follow-up of 92,675 operations performed 1978-1990.

Authors:  H Malchau; P Herberts; L Ahnfelt
Journal:  Acta Orthop Scand       Date:  1993-10

7.  Thromboprophylaxis and death after total hip replacement.

Authors:  D W Murray; A R Britton; C J Bulstrode
Journal:  J Bone Joint Surg Br       Date:  1996-11

8.  Twenty years of total hip arthroplasty in Taranaki: a survival analysis.

Authors:  C W Hoffman; T G Lynskey; V Hadlow
Journal:  Aust N Z J Surg       Date:  1994-08

9.  A meta-analysis of methods to prevent venous thromboembolism following total hip replacement.

Authors:  T F Imperiale; T Speroff
Journal:  JAMA       Date:  1994-06-08       Impact factor: 56.272

10.  Effect of ultraclean air in operating rooms on deep sepsis in the joint after total hip or knee replacement: a randomised study.

Authors:  O M Lidwell; E J Lowbury; W Whyte; R Blowers; S J Stanley; D Lowe
Journal:  Br Med J (Clin Res Ed)       Date:  1982-07-03
View more
  1 in total

1.  A comparison of Rasch with Likert scoring to discriminate between patients' evaluations of total hip replacement surgery.

Authors:  R Fitzpatrick; J M Norquist; C Jenkinson; B C Reeves; R W Morris; D W Murray; P J Gregg
Journal:  Qual Life Res       Date:  2004-03       Impact factor: 4.147

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.